サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1643897

診断用皮膚科機器の世界市場（2025年～2033年）

Global Diagnostic Dermatology Equipment Market - 2025-2033

出版日
ページ情報
英文 196 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.35円
診断用皮膚科機器の世界市場（2025年～2033年）
出版日: 2025年01月27日
発行: DataM Intelligence
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の診断用皮膚科機器の市場規模は、2024年に108億米ドルに達し、2033年には224億米ドルに達すると予測され、予測期間2025年～2033年にはCAGR5.9%で成長する見込みです。

診断用皮膚科機器市場は、皮膚がん、乾癬、湿疹、色素沈着障害などの皮膚疾患を特定、監視、評価するために様々なツールや技術を使用する重要な分野です。皮膚鏡、反射型共焦点顕微鏡、光干渉断層計などのこれらの機器は、正確で非侵襲的な早期診断を提供し、患者の転帰を改善します。同市場は、AI統合や遠隔皮膚科ソリューションなどの技術的進歩によって牽引されています。同分野は皮膚科医療において重要な役割を果たしており、伝統的な手法と現代的なデジタル、AI主導のソリューションとのギャップを埋めています。

市場力学：

促進要因と抑制要因

皮膚疾患の有病率の増加

診断用皮膚科機器の世界市場は、にきび、乾癬、湿疹、メラノーマなどの皮膚疾患の有病率の増加によって牽引されており、これらの皮膚疾患は、汚染、ライフスタイルの変化、長時間の日光暴露などの要因によって、より一般的になってきています。世界保健機関（WHO）の報告によると、皮膚疾患は毎年数百万人に影響を及ぼしており、皮膚内視鏡、画像診断システム、生検装置などの高度な診断ツールの需要につながっています。皮膚の健康に対する意識の高まりと定期的な皮膚科検診は、さらにこれらの機器の採用を促し、市場の成長を確実なものにしています。

例えば、米国皮膚科学会によると、にきびは米国で最も一般的な皮膚疾患であり、年間5,000万人の米国人が罹患しています。にきびにはさまざまなタイプがあり、一律のアプローチは適しません。認定皮膚科医であれば、肌質やニキビのタイプに応じて診断し、適切な治療を決定することができます。内服薬、外用薬、市販薬、処方薬など、さまざまな治療法があります。にきびは一般的に思春期に始まり、青年や若年成人に発症しますが、人生のどの段階でも発症する可能性があります。成人にきびは増加の一途をたどっており、女性の最大15％が罹患しています。12～24歳の約85％が軽度のにきびを経験しています。

診断用皮膚科機器の高い費用

皮膚内視鏡、共焦点顕微鏡、イメージングシステムを含む診断用皮膚科機器の高価格は、特に中低所得地域における市場成長の大きな障害となっています。これらの高度なツールは初期投資が高額であるため、小規模のクリニックやヘルスケア施設では利用しにくくなっています。また、メンテナンスや運用にかかる費用も経済的負担に拍車をかけ、普及をさらに制限しています。この問題は、ヘルスケア予算が限られている地域や、皮膚科診療が優先されない地域では特に問題となります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 皮膚疾患の増加
    • 抑制要因
      • 診断用皮膚科機器のコストが高い
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 製品タイプ別

  • イメージングデバイス
  • 顕微鏡装置
  • 生検装置
  • その他の診断装置

第7章 技術別

  • デジタルイメージング
  • AIを活用した診断ツール
  • 光学イメージング
  • 分子イメージング

第8章 用途別

  • 皮膚がんの診断
  • 乾癬の診断
  • 湿疹の診断
  • ニキビの診断
  • 色素異常症の診断
  • 血管病変の診断
  • その他

第9章 エンドユーザー別

  • 病院
  • 皮膚科クリニック
  • 外来手術センター
  • 研究ラボ

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第12章 企業プロファイル

  • Canfield Scientific, Inc
    • 会社概要
    • 製品ポートフォリオ
      • 製品説明
      • 製品の主要業績評価指標（KPI）
      • 実績および予測の製品販売
      • 製品販売量
    • 財務概要
      • 企業収益
      • 地域別収益分配
      • 収益予測
    • 主な発展
      • 合併と買収
      • 主な製品開発活動
      • 規制当局の承認等
    • SWOT分析
  • FotoFinder Systems GmbH
  • 3Derm Systems, Inc.
  • HEINE Optotechnik GmbH & Co. KG
  • AMD Global Telemedicine, Inc.
  • Hill-Rom Holdings, Inc.
  • Derma Medical Systems
  • Leica Microsystems
  • Caliber I.D.（Formerly Lucid, Inc.）
  • GE Healthcare
  • Similar data will be provided for each market player.
  • VivaScope GmbH
    • パイプライン製品の説明
    • 製品の主要業績評価指標（KPI）
    • 主な活動
    • 市場参入のタイムライン
    • 製品普及率
    • 売上推定と予測
  • Veriskin, Inc.
  • VisualDx
  • FotoFinder Hub
  • TeleSkin

第12章 付録

目次
Product Code: MD9062

The global diagnostic dermatology equipment market reached US$ 10.8 Billion in 2024 and is expected to reach US$ 22.4 Billion by 2033, growing at a CAGR of 5.9% during the forecast period 2025-2033.

The diagnostic dermatology equipment market is a crucial sector that uses various tools and technologies to identify, monitor, and evaluate skin conditions like skin cancer, psoriasis, eczema, and pigmentation disorders. these devices, like dermatoscopes, reflectance confocal microscopes, and optical coherence tomography, provide accurate, non-invasive, and early diagnosis, improving patient outcomes. the market is driven by technological advancements, such as ai integration and teledermatology solutions. the sector plays a critical role in dermatological care, bridging the gap between traditional methods and modern, digital, and ai-driven solutions.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Skin Disorders

The global market for diagnostic dermatology equipment is driven by the increasing prevalence of skin disorders like acne, psoriasis, eczema, and melanoma, which are becoming more prevalent due to factors like pollution, lifestyle changes, and prolonged sun exposure. The World Health Organization reports that skin diseases affect millions annually, leading to a demand for advanced diagnostic tools like dermatoscopes, imaging systems, and biopsy devices. The growing awareness of skin health and routine dermatological checkups further encourages the adoption of these devices, ensuring market growth.

For instance, according to American Academy of Dermatology Association, Acne is the most common skin condition in the US, affecting up to 50 million Americans annually. Different types of acne exist, making a one-size-fits-all approach unsuitable. A board-certified dermatologist can diagnose and determine the appropriate treatment based on the skin type and acne type. There are various treatments available, including oral, topical, over-the-counter, and prescription medications. Acne typically begins in puberty and affects adolescents and young adults, but can occur at any stage of life. Adult acne continues to increase, affecting up to 15% of women. Approximately 85% of people aged 12-24 experience minor acne.

High Cost of Diagnostic Dermatology Equipment

The high cost of diagnostic dermatology equipment, including dermatoscopes, confocal microscopes, and imaging systems, is a major obstacle to market growth, especially in low- and middle-income regions. These advanced tools are expensive upfront, making them less accessible to smaller clinics and healthcare facilities. Maintenance and operational expenses also add to the financial burden, further limiting their adoption. This issue is particularly problematic in areas with limited healthcare budgets or where dermatological services are not prioritized.

Segment Analysis

The global diagnostic dermatology equipment market is segmented based on product type, technology, Application, end user and region.

Product Type:

Imaging Devices segment is expected to dominate the Diagnostic Dermatology Equipment market share

The imaging devices segment holds a major portion of the diagnostic dermatology equipment market share and is expected to continue to hold a significant portion of the diagnostic dermatology equipment market share during the forecast period.

The imaging devices segment is a key player in the global diagnostic dermatology equipment market, offering accurate and non-invasive visualization of skin conditions. It includes devices like dermatoscopes, confocal microscopes, and multispectral imaging systems, which diagnose various dermatological disorders like melanoma, eczema, and psoriasis. These devices provide high-resolution images and advanced features like digital storage and AI-driven analytics. The growing prevalence of skin disorders and advancements in imaging technologies drive demand for these devices.

For instance, in June 2023, DeepX Diagnostics has received FDA clearance for its digital dermatoscope DermoSight, a tool for teledermatology screening of suspected skin cancer lesions in the US.

Hence, the FDA cleared DeepX Diagnostics' DermoSight digital dermatoscope in June 2023, indicating the growing use of advanced imaging tools in teledermatology, especially for skin cancer screening. This approval boosts the credibility and market potential of digital dermatoscopes, boosting healthcare provider trust and driving global imaging device growth.

End User:-

Hospitals segment is the fastest-growing segment in diagnostic dermatology equipment market share

The hospitals segment is the fastest-growing segment in the diagnostic dermatology equipment market share and is expected to hold the market share over the forecast period.

Hospitals are key players in the global diagnostic dermatology equipment market, focusing on diagnosing and managing complex conditions like melanoma, psoriasis, and eczema. They invest heavily in advanced diagnostic tools like imaging devices, biopsy systems, and AI-powered solutions to improve skin disease detection accuracy. Hospitals also adopt teledermatology platforms to enhance accessibility and patient outcomes. The rising prevalence of skin disorders and demand for specialized dermatological care are driving their contributions to market growth.

For instance, in January 2025, Lux Hospitals in Hyderabad has introduced the ENDOANAL Real-Time Ultrasound-Guided Laser Procedure for treating Fistula in Ano, pioneered by Dr. Samhitha Reddy Marpali. With over eight years of experience, Dr. Marpali specializes in treating various proctology disorders, including Piles, Fistulas, Anal Fissures, Pilonidal Sinus, Colon and Rectum Cancers, and other complex colorectal conditions. She offers world-class care to patients.

Geographical Analysis

North America is expected to hold a significant position in the Diagnostic Dermatology Equipment market share

North America holds a substantial position in the diagnostic dermatology equipment market and is expected to hold most of the market share due to due to its advanced healthcare infrastructure, FDA approvals, product launches, advanced technologies, increased awareness about early diagnosis and preventive dermatology, favorable reimbursement policies, key market players, and ongoing R&D initiatives, which contribute to its market leadership.

For instance, in June 2024, the US FDA has approved DermaSensor, the first AI-enabled medical device for skin cancer detection in primary care. This marks a new regulatory precedent for medical devices incorporating AI and ML technologies in dermatology. The device, already approved in the European Union and Australia, is considered a milestone in the industry, highlighting the clinical evidence and regulatory implications of AI-enabled technologies.

Europe is growing at the fastest pace in the Diagnostic Dermatology Equipment market

Europe holds the fastest pace in the diagnostic dermatology equipment market and is expected to hold most of the market share due to increasing incidence of skin diseases like atopic dermatitis and psoriasis, supported by government initiatives and public health campaigns. The aging population and well-established healthcare systems contribute to increased demand for advanced diagnostic tools. Investments in dermatology-focused research and development further support market expansion.

For instance, Eczema, also known as atopic dermatitis, is a prevalent skin disease in the UK, affecting 1 in 5 children and 1 in 10 adults. It is the leading contributor to skin-related disability, with severe cases more likely to develop depression. The disease burden is highest in disability-adjusted life-years (DALYs).

Hence, the disease contributes to skin-related disability and severe complications like depression, necessitating advanced diagnostic tools for early detection and effective management. The burden of disability-adjusted life-years underscores the need for accurate and efficient dermatological solutions, driving demand for innovative equipment in clinical and research settings.

Competitive Landscape

The major global players in the diagnostic dermatology equipment market include Canfield Scientific, Inc, FotoFinder Systems GmbH, 3Derm Systems, Inc, HEINE Optotechnik GmbH & Co. KG, AMD Global Telemedicine, Inc., Hill-Rom Holdings, Inc., Derma Medical Systems, Leica, Microsystems, Caliber I.D. (Formerly Lucid, Inc.), GE Healthcare and among others.

Key Developments

  • In October 2024, The American Academy of Dermatology is launched an initiative to highlight the debilitating condition of hidradenitis suppurativa (HS), a chronic progressive condition causing painful bumps in the armpits, thighs, and groin. HS is often misdiagnosed or undiagnosed, leading to scarring, pain, and impaired mobility. Patients with HS often suffer from depression, self-esteem issues, and daily living challenges, including work.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global diagnostic dermatology equipment market report delivers a detailed analysis with 70 key tables, more than 69 visually impactful figures, and 205 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Technology
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Skin Disorders
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Diagnostic Dermatology Equipment
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Imaging Devices*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Microscopy Devices
  • 6.4. Biopsy Devices
  • 6.5. Other Diagnostic Devices

7. By Technology

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 7.1.2. Market Attractiveness Index, By Technology
  • 7.2. Digital Imaging*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. AI-Powered Diagnostic Tools
  • 7.4. Optical Imaging
  • 7.5. Molecular Imaging

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Skin Cancer Diagnosis*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Psoriasis Diagnosis
  • 8.4. Eczema Diagnosis
  • 8.5. Acne Diagnosis
  • 8.6. Pigmentation Disorders Diagnosis
  • 8.7. Vascular Lesions Diagnosis
  • 8.8. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Dermatology Clinics
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Research Laboratories

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

  • 12.1. Canfield Scientific, Inc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals etc.
    • 12.1.5. SWOT Analysis
  • 12.2. FotoFinder Systems GmbH
  • 12.3. 3Derm Systems, Inc.
  • 12.4. HEINE Optotechnik GmbH & Co. KG
  • 12.5. AMD Global Telemedicine, Inc.
  • 12.6. Hill-Rom Holdings, Inc.
  • 12.7. Derma Medical Systems
  • 12.8. Leica Microsystems
  • 12.9. Caliber I.D. (Formerly Lucid, Inc.)
  • 12.10. GE Healthcare
  • Similar data will be provided for each market player.

Emerging Market Players

  • 12.11. VivaScope GmbH*
    • 12.11.1. Pipeline Products Description
    • 12.11.2. Product Key Performance Indicators (KPIs)
    • 12.11.3. Key Activities
    • 12.11.4. Market Entry Timelines
    • 12.11.5. Product Penetration Rate
    • 12.11.6. Sales Estimation and Projections
  • 12.12. Veriskin, Inc.
  • 12.13. VisualDx
  • 12.14. FotoFinder Hub
  • 12.15. TeleSkin
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us